Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07117383

Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject

A Phase 1 Pharmacokinetic Study Comparing Hezkue® (ASP-001), Hezkue Turbo® (ASP-001.1), and Select Commercially Available Sildenafil Products Under Fed Conditions in Healthy Adult Male Subjects

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
72 (estimated)
Sponsor
Aspargo Labs, Inc · Industry
Sex
Male
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to compare how different sildenafil formulations are absorbed and tolerated in healthy adult males under fed conditions. The main questions it aims to answer are: Do Hezkue and Hezkue Turbo differ in absorption compared to other commercial sildenafil products? Are there any differences in safety or tolerability between the products? Researchers will compare multiple formulations to evaluate differences in drug absorption and side effects.

Detailed description

The goal of this clinical trial is to learn how different formulations of sildenafil-used to treat erectile dysfunction-are absorbed in the body when taken with food, and to understand how safe and well-tolerated they are in healthy adult males. The main questions it aims to answer are: How do the blood levels of sildenafil compare between Hezkue, Hezkue Turbo, and other commercial sildenafil products? Do differences in formulation (such as particle size or combination with tadalafil) affect the absorption or safety profile? Researchers will compare Hezkue and Hezkue Turbo to other sildenafil-containing products (such as Pfizer Viagra, BlueChew, and Ro Sparks) to see if there are differences in how quickly and how much of the drug enters the bloodstream. Participants will: * Take a single oral dose of one of the test products after eating a high-fat meal. * Have blood samples taken over a 4-hour period to measure drug levels. * Be monitored for side effects and overall health for up to 4 days after each dose. * Have the option to return for additional visits to test other products, with a 4-day break in between.

Conditions

Interventions

TypeNameDescription
DEVICEASP-001.1Bottle/pump containing ASP-001.1 suspension
DRUGASP-001Oral liquid suspension of sildenafil
DRUGCommercial Sildenafil and Sildenafil/Tadalafil ProductsA selection of marketed sildenafil or sildenafil + tadalafil products used as comparators. Includes tablets and chewables such as Viagra®, Galotam, BlueChew, Aristo Sildaristo, Lemonaid Viagra, Ro Sparks, Hims Hard Mints, and Hello Cake ED Cake Meds.

Timeline

Start date
2026-01-01
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2025-08-12
Last updated
2025-12-12

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07117383. Inclusion in this directory is not an endorsement.